Truist Securities Reiterates Buy on Ovintiv, Raises Price Target to $73
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsReiterationPrice Target
Truist Securities analyst Gabe Daoud reiterates Ovintiv (NYSE:OVV) with a Buy and raises the price target from $66 to $73.
Truist Securities analyst Gabe Daoud reiterates Ovintiv (NYSE:OVV) with a Buy and raises the price target from $66 to $73.